Target Name: SCAPER
NCBI ID: G49855
Review Report on SCAPER Target / Biomarker Content of Review Report on SCAPER Target / Biomarker
SCAPER
Other Name(s): S-phase cyclin A associated protein in the ER | zinc finger protein 291 | S phase cyclin A-associated protein in the endoplasmic reticulum | S phase cyclin A-associated protein in the endoplasmic reticulum (isoform b) | S-phase cyclin A associated protein in the ER, transcript variant 1 | S-phase cyclin A associated protein in the ER, transcript variant 2 | Zinc finger protein 291 | S phase cyclin A-associated protein in the endoplasmic reticulum (isoform a) | SCAPER variant 1 | Zfp291 | KIAA1454 | ZNF291 | SCAPE_HUMAN | IDDRP | MSTP063 | SCAPER variant 2 | S phase cyclin A-associated protein in the ER

Identification of A Potential Drug Target Or Biomarker for SCAPER

SCAPER (S-phase Cyclin A-associated Protein in the ER) is a protein that is expressed in the endoplasmic reticulum (ER) and is involved in the regulation of cell cycle progression. It is a key player in the S-phase, a stage of cell division where the DNA is replicated. SCAPER has been shown to play a crucial role in the regulation of cell cycle progression and has accordingly been identified as a potential drug target or biomarker.

The S-phase is a critical stage of cell division that occurs during the G1 phase. During this stage, the cell prepares for cell division by producing all of the necessary organelles, including the chromosomes in the nucleus. The S-phase is also the stage at which the DNA is replicated.SCAPER is a protein that is expressed in the ER and is involved in the regulation of the S-phase. It is a key player in the S-phase, a stage of cell division where the DNA is replicated. SCAPER has been shown to play a crucial role in the regulation of cell cycle progression and has accordingly been identified as a potential drug target or biomarker.

SCAPER is a protein that is composed of 252 amino acids. It has a molecular weight of 31 kDa and a pre-calculated pI of 5.6. It is expressed in the ER and is involved in the regulation of cell cycle progression.

SCAPER has been shown to play a crucial role in the regulation of cell cycle progression. During the S-phase, SCAPER is involved in the assembly and disassembly of the mitochondrial DNA replication complex. This complex is responsible for replicating the DNA in the S -phase and is composed of several different proteins, including the cyclin D1 protein.

SCAPER has also been shown to be involved in the regulation of cell apoptosis. During the S-phase, SCAPER has been shown to be involved in the regulation of cell apoptosis. This is a process by which cells commit suicide to remove damaged or unneeded chromosomes.

SCAPER has also been shown to be involved in the regulation of protein synthesis. During the S-phase, SCAPER has been shown to be involved in the regulation of protein synthesis. This is the process by which cells produce the proteins that are necessary for cell growth and division.

SCAPER has also been shown to be involved in the regulation of cell migration. During the S-phase, SCAPER has been shown to be involved in the regulation of cell migration. This is the process by which cells move from one location to another in the body.

In conclusion, SCAPER is a protein that is expressed in the ER and is involved in the regulation of cell cycle progression, protein synthesis, apoptosis, and migration. It has accordingly been identified as a potential drug target or biomarker. Further research is needed to fully understand the role of SCAPER in cell biology and to determine its potential as a drug.

Protein Name: S-phase Cyclin A Associated Protein In The ER

Functions: CCNA2/CDK2 regulatory protein that transiently maintains CCNA2 in the cytoplasm

The "SCAPER Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCAPER comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SCARA3 | SCARA5 | SCARB1 | SCARB2 | SCARF1 | SCARF2 | SCARNA1 | SCARNA10 | SCARNA11 | SCARNA12 | SCARNA13 | SCARNA14 | SCARNA15 | SCARNA16 | SCARNA17 | SCARNA18 | SCARNA2 | SCARNA20 | SCARNA21 | SCARNA22 | SCARNA23 | SCARNA27 | SCARNA28 | SCARNA3 | SCARNA4 | SCARNA5 | SCARNA6 | SCARNA7 | SCARNA8 | SCARNA9 | SCARNA9L | SCART1 | SCAT1 | SCCPDH | SCD | SCD5 | SCDP1 | SCEL | SCF (SKP1-CUL1-F-box protein) Ubiquitin Ligase Complex | SCF Ubiquitin Ligase Complex | SCFD1 | SCFD2 | SCG2 | SCG3 | SCG5 | SCGB1A1 | SCGB1B2P | SCGB1C1 | SCGB1D1 | SCGB1D2 | SCGB1D4 | SCGB2A1 | SCGB2A2 | SCGB2B2 | SCGB3A1 | SCGB3A2 | SCGN | SCHIP1 | SCHLAP1 | SCIMP | SCIN | SCIRT | SCLT1 | SCLY | SCMH1 | SCML1 | SCML2 | SCML4 | SCN10A | SCN11A | SCN1A | SCN1A-AS1 | SCN1B | SCN2A | SCN2B | SCN3A | SCN3B | SCN4A | SCN4B | SCN5A | SCN7A | SCN8A | SCN9A | SCNM1 | SCNN1A | SCNN1B | SCNN1D | SCNN1G | SCO1 | SCO2 | SCOC | SCOC-AS1 | SCP2 | SCP2D1 | SCP2D1-AS1 | SCPEP1 | SCRG1 | SCRIB | SCRN1 | SCRN2